Moberg wants more OTC deals in the US

24 February 2014 - Deborah Wilkes

Archived

Moberg Pharma is seeking further acquisitions and in-licensing opportunities, according to chief executive officer Peter Wolpert, and is particularly keen to follow up its purchase of three established brands from Bayer HealthCare with more deals involving non-prescription products for the US market.

Click tags below for more information on topics:

Moberg

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: